Obstructive Sleep Apnea for Somali-Americans
(Somali OSA Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to explore how obstructive sleep apnea, a condition where breathing repeatedly stops and starts during sleep, affects people differently based on ethnic background and gender. Researchers will compare Somali patients with obstructive sleep apnea to those without it and to individuals from other ethnic groups to identify risk factors for heart-related diseases. The goal is to understand the unique sleep patterns of individuals of African descent. Adults of Somali, African, Asian, or European descent, with or without known sleep apnea, may be suitable participants. As an unphased study, this trial offers a unique opportunity to contribute to groundbreaking research that could lead to better, personalized treatments for diverse populations.
Why are researchers excited about this trial?
Researchers are excited about this clinical trial because it focuses on obstructive sleep apnea specifically among Somali-Americans, a group that may have unique physiological or cultural factors affecting the condition. Unlike existing treatments like CPAP machines or oral appliances, which may not be as effective or comfortable for everyone, this study seeks to uncover insights specific to this demographic. By tailoring approaches that consider genetic, environmental, or lifestyle aspects unique to Somali-Americans, the trial aims to enhance treatment efficacy and improve overall patient outcomes in this community.
Who Is on the Research Team?
Virend Somers, MD
Principal Investigator
Mayo Clinic
Are You a Good Fit for This Trial?
Inclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Baseline Assessment
Participants undergo a sleep study, physical examination, and various tests including blood and urine samples, ultrasound, CT scan, DEXA scan, and cardiopulmonary tests
Follow-up
Participants are monitored for the prevalence and severity of obstructive sleep apnea and associated cardiovascular risk factors
What Are the Treatments Tested in This Trial?
Find a Clinic Near You
Who Is Running the Clinical Trial?
Mayo Clinic
Lead Sponsor
Sleep Number Corporation
Collaborator